Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Cash from Financing Activities: 2012-2025

Historic Cash from Financing Activities for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $3.0 million.

  • Veracyte's Cash from Financing Activities fell 71.07% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year decrease of 185.33%. This contributed to the annual value of $4.9 million for FY2024, which is 72.86% up from last year.
  • As of Q3 2025, Veracyte's Cash from Financing Activities stood at $3.0 million, which was up 625.97% from -$566,000 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Cash from Financing Activities registered a high of $591.0 million during Q1 2021, and its lowest value of -$6.5 million during Q1 2025.
  • Its 3-year average for Cash from Financing Activities is $333,455, with a median of $110,000 in 2023.
  • Per our database at Business Quant, Veracyte's Cash from Financing Activities spiked by 269,968.49% in 2021 and then slumped by 5,045.45% in 2025.
  • Veracyte's Cash from Financing Activities (Quarterly) stood at $173,000 in 2021, then crashed by 46.24% to $93,000 in 2022, then soared by 593.55% to $645,000 in 2023, then slumped by 799.22% to -$4.5 million in 2024, then crashed by 71.07% to $3.0 million in 2025.
  • Its Cash from Financing Activities stands at $3.0 million for Q3 2025, versus -$566,000 for Q2 2025 and -$6.5 million for Q1 2025.